SME Export Track 100

This Nottingham company works with research organisations to develop drugs for illnesses such as cancer, respiratory disease and Alzheimer’s. Simon Hirst, 52, started Sygnature in 2004 and in January it took a stake in Cheshire-based Peak Proteins. It has customers in America, Germany, Denmark and Australia and overseas sales grew to £5.3m last year.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanySygnature Discovery
ActivityNew drug researcher
2 yr av intl sales growth % pa53.83
International sales £000s5,310
Total sales £000s11,407

If applicable:

* Supplied by company † Annualised figure